Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2013, Article ID 376454, 13 pages
http://dx.doi.org/10.1155/2013/376454
Review Article

Variants of Insulin-Signaling Inhibitor Genes in Type 2 Diabetes and Related Metabolic Abnormalities

Department of Medical and Surgical Sciences, University of Catanzaro “Magna Graecia”, 88100 Catanzaro, Italy

Received 1 March 2013; Accepted 23 April 2013

Academic Editor: Eusebio Chiefari

Copyright © 2013 Carlo de Lorenzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Pessin and A. R. Saltiel, “Signaling pathways in insulin action: molecular targets of insulin resistance,” The Journal of Clinical Investigation, vol. 106, no. 2, pp. 165–169, 2000. View at Google Scholar · View at Scopus
  2. G. Sesti, “Pathophysiology of insulin resistance,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 20, no. 4, pp. 665–679, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. I. D. Goldfine, B. A. Maddux, J. F. Youngren et al., “The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities,” Endocrine Reviews, vol. 29, no. 1, pp. 62–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Hashimoto, E. P. Feener, W. R. Zhang, and B. J. Goldstein, “Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen- related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain,” The Journal of Biological Chemistry, vol. 267, no. 20, pp. 13811–13814, 1992. View at Google Scholar · View at Scopus
  5. B. L. Seely, P. A. Staubs, D. R. Reichart et al., “Protein tyrosine phosphatase 1B interacts with the activated insulin receptor,” Diabetes, vol. 45, no. 10, pp. 1379–1385, 1996. View at Publisher · View at Google Scholar
  6. X. Pesesse, S. Deleu, F. de Smedt, L. Drayer, and C. Erneux, “Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP,” Biochemical and Biophysical Research Communications, vol. 239, no. 3, pp. 697–700, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Du, S. Herzig, R. N. Kulkarni, and M. Montminy, “TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver,” Science, vol. 300, no. 5625, pp. 1574–1577, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. E. Lebovitz, “Insulin resistance—a common link between type 2 diabetes and cardiovascular disease,” Diabetes, Obesity and Metabolism, vol. 8, no. 3, pp. 237–249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Prudente, E. Morini, and V. Trischitta, “Insulin signaling regulating genes: effect on T2DM and cardiovascular risk,” Nature Reviews Endocrinology, vol. 5, no. 12, pp. 682–693, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. H. Kwak and K. S. Park, “Genetics of type 2 diabetes and potential clinical implications,” Archives of Pharmacal Research, vol. 36, no. 2, pp. 167–177, 2013. View at Publisher · View at Google Scholar
  11. B. A. Maddux, Y. N. Chang, D. Accili, O. P. McGuinness, J. F. Youngren, and I. D. Goldfine, “Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia,” American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 4, pp. E746–E749, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Gijsbers, H. Ceulemans, and M. Bollen, “Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/phosphodiesterase NPP1,” The Biochemical Journal, vol. 371, no. 2, pp. 321–330, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. B. V. Costanzo, V. Trischitta, R. Di Paola et al., “The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121),” Diabetes, vol. 50, no. 4, pp. 831–836, 2001. View at Google Scholar · View at Scopus
  14. R. Di Paola, N. Caporarello, A. Marucci et al., “ENPP1 affects insulin action and secretion: evidences from in vitro studies,” PLoS ONE, vol. 6, no. 5, article e19462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Baratta, P. Rossetti, S. Prudente et al., “Role of the ENPP1 K121Q polymorphism in glucose homeostasis,” Diabetes, vol. 57, no. 12, pp. 3360–3364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Pizzuti, L. Frittitta, A. Argiolas et al., “A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance,” Diabetes, vol. 48, no. 9, pp. 1881–1884, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Abate, L. Carulli, A. Cabo-Chan, M. Chandalia, P. G. Snell, and S. M. Grundy, “Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance,” The Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5927–5934, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Abate, M. Chandalia, P. Satija et al., “ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes,” Diabetes, vol. 54, no. 4, pp. 1207–1213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Baratta, R. Di Paola, D. Spampinato et al., “Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARγ2 (P12A) polymorphisms,” Journal of Molecular Medicine, vol. 81, no. 11, pp. 718–723, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Frittitta, R. Baratta, D. Spampinato et al., “The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5888–5891, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. González-Sánchez, M. T. Martínez-Larrad, C. Fernández-Pérez, A. Kubaszek, M. Laakso, and M. Serrano-Ríos, “K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population,” Obesity Research, vol. 11, no. 5, pp. 603–605, 2003. View at Publisher · View at Google Scholar
  22. H. F. Gu, P. Almgren, E. Lindholm et al., “Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis,” Diabetes, vol. 49, no. 9, pp. 1601–1603, 2000. View at Google Scholar · View at Scopus
  23. K. Hamaguchi, H. Terao, Y. Kusuda et al., “The PC-1 Q121 allele is exceptionally prevalent in the Dominican Republic and is associated with type 2 diabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 3, pp. 1359–1364, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Kubaszek, J. Pihlajamäki, P. Karhapää, I. Vauhkonen, and M. Laakso, “The K121Q polymorphism of the PC-1 gene is associated with insulin resistance but not with dyslipidemia,” Diabetes Care, vol. 26, no. 2, pp. 464–467, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Kubaszek, A. Markkanen, J. G. Eriksson et al., “The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 5, pp. 2044–2047, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Tasic, M. Milojkovic, R. Sunder-Plassmann, G. Lazarevic, N. M. Tasic, and V. Stefanovic, “The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome in patients with coronary heart disease,” Clinica Chimica Acta, vol. 377, no. 1-2, pp. 237–242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Bacci, O. Ludovico, S. Prudente et al., “The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction,” Diabetes, vol. 54, no. 10, pp. 3021–3025, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Bochenski, G. Placha, K. Wanic et al., “New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals,” Diabetes, vol. 55, no. 9, pp. 2626–2630, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Meyre, N. Bouatia-Naji, A. Tounian et al., “Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes,” Nature Genetics, vol. 37, no. 8, pp. 863–867, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Matsuoka, A. Patki, H. K. Tiwari et al., “Association of K121Q polymorphism in ENPP1 (PC-1) with BMI in Caucasian and African-American adults,” International Journal of Obesity, vol. 30, no. 2, pp. 233–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. El Achhab, D. Meyre, N. Bouatia-Naji et al., “Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population,” Diabetes & Metabolism, vol. 35, no. 1, pp. 37–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. B. McAteer, S. Prudente, S. Bacci et al., “The ENPP1 K121Q polymorphism is associated with type 2 diabetes in european populations evidence from an updated meta-analysis in 42,042 subjects,” Diabetes, vol. 57, no. 4, pp. 1125–1130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Zeggini, L. J. Scott, R. Saxena, and B. F. Voight, “Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes,” Nature Genetics, vol. 40, no. 5, pp. 638–645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. T. M. Frayling, S. Wiltshire, G. A. Hitman et al., “Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11,” Diabetes, vol. 52, no. 7, pp. 1857–1863, 2003. View at Google Scholar · View at Scopus
  35. A. F. Moore, K. A. Jablonski, C. C. Mason et al., “The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 449–455, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Müssig, M. Heni, C. Thamer et al., “The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention,” Diabetologia, vol. 53, no. 3, pp. 504–509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Maranghi, S. Prudente, L. D’Erasmo et al., “The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals,” Nutrition, Metabolism, and Cardiovascular Diseases, 2012. View at Publisher · View at Google Scholar
  38. S. Prudente, M. Chandalia, E. Morini et al., “The Q121/Q121 genotype of ENPP1/PC-1 is associated with lower BMI in non-diabetic whites,” Obesity, vol. 15, no. 1, pp. 1–4, 2007. View at Google Scholar · View at Scopus
  39. C. Wan, T. Zhang, B. Wang et al., “Obesity risk associated with the K121Q polymorphism of the glycoprotein PC-1 gene,” Diabetes, Obesity & Metabolism, vol. 8, no. 6, pp. 703–708, 2006. View at Publisher · View at Google Scholar
  40. Y. Böttcher, A. Körner, T. Reinehr et al., “ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children,” The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 12, pp. 4948–4952, 2006. View at Publisher · View at Google Scholar
  41. S. Bacci, R. Di Paola, C. Menzaghi et al., “ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 10, pp. 1678–1683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Endler, C. Mannhalter, H. Sunder-Plassmann et al., “The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction,” Journal of Molecular Medicine, vol. 80, no. 12, pp. 791–795, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Bacci, S. Rizza, S. Prudente et al., “The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients,” Diabetes, vol. 60, no. 3, pp. 1000–1007, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. H. N. Lyon, J. C. Florez, T. Bersaglieri et al., “Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity,” Diabetes, vol. 55, no. 11, pp. 3180–3184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Frittitta, T. Ercolino, M. Bozzali et al., “A cluster of three single nucleotide polymorphisms in the 3’-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities,” Diabetes, vol. 50, no. 8, pp. 1952–1955, 2001. View at Google Scholar · View at Scopus
  46. M. J. Chagnon, N. Uetani, and M. L. Tremblay, “Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases,” Biochemistry and Cell Biology, vol. 82, no. 6, pp. 664–675, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. J. M. Zabolotny, Y. B. Kim, O. D. Peroni et al., “Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5187–5192, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. D. T. Kulas, W. R. Zhang, B. J. Goldstein, R. W. Furlanetto, and R. A. Mooney, “Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR,” The Journal of Biological Chemistry, vol. 270, no. 6, pp. 2435–2438, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Ahmad, R. V. Considine, and B. J. Goldstein, “Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects,” The Journal of Clinical Investigation, vol. 95, no. 6, pp. 2806–2812, 1995. View at Google Scholar · View at Scopus
  50. F. Ahmad, J. L. Azevedo, R. Cortright, G. L. Dohm, and B. J. Goldstein, “Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes,” The Journal of Clinical Investigation, vol. 100, no. 2, pp. 449–458, 1997. View at Google Scholar · View at Scopus
  51. G. Miscio, V. Tassi, A. Coco et al., “The allelic variant of LAR gene promoter -127 bp T→A is associated with reduced risk of obesity and other features related to insulin resistance,” Journal of Molecular Medicine, vol. 82, no. 7, pp. 459–466, 2004. View at Google Scholar · View at Scopus
  52. C. Menzaghi, G. Paroni, C. de Bonis et al., “The protein tyrosine phosphatase receptor type f (PTPRF) locus is associated with coronary artery disease in type 2 diabetes,” Journal of Internal Medicine, vol. 263, no. 6, pp. 653–654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Norris, F. Norris, D. H. Kono et al., “Expression of protein-tyrosine phosphatases in the major insulin target tissues,” The FEBS Letters, vol. 415, no. 3, pp. 243–248, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. M. J. Chagnon, M. Elchebly, N. Uetani et al., “Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 7, pp. 755–763, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. E. C. Långberg, H. F. Gu, S. Nordman, S. Efendic, and C. G. Ostenson, “Genetic variation in receptor protein tyrosine phosphatase sigma is associated with type 2 diabetes in Swedish Caucasians,” European Journal of Endocrinology/European Federation of Endocrine Societies, vol. 157, no. 4, pp. 459–464, 2007. View at Publisher · View at Google Scholar
  56. F. J. Tsai, C. F. Yang, C. C. Chen et al., “A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese,” PLoS Genetics, vol. 6, no. 2, Article ID e1000847, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. C. Chang, Y. F. Chiu, P. H. Liu et al., “Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort,” Clinical Endocrinology, vol. 76, no. 3, pp. 365–372, 2012. View at Publisher · View at Google Scholar
  58. Q. Pei, Q. Huang, G. P. Yang et al., “PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients’response to pioglitazone in China,” Acta Pharmacologica Sinica, vol. 34, no. 2, pp. 255–261, 2013. View at Publisher · View at Google Scholar
  59. F. Bauer, N. C. Onland-Moret, O. M. N. Charlotte et al., “PTPN1 polymorphisms are associated with total and low-density lipoprotein cholesterol,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 17, no. 1, pp. 28–34, 2010. View at Publisher · View at Google Scholar
  60. F. Bauer, N. C. Onland-Moret, A. G. Niehoff et al., “No association of PTPN1 polymorphisms with macronutrient intake and measures of adiposity,” Obesity, vol. 16, no. 12, pp. 2767–2771, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. J. L. Bento, N. D. Palmer, J. C. Mychaleckyj et al., “Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes,” Diabetes, vol. 53, no. 11, pp. 3007–3012, 2004. View at Publisher · View at Google Scholar
  62. N. D. Palmer, J. L. Bento, J. C. Mychaleckyj et al., “Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: The Insulin Resistance Atherosclerosis Study (IRAS) family study,” Diabetes, vol. 53, no. 11, pp. 3013–3019, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. N. J. Spencer-Jones, X. Wang, H. Snieder, T. D. Spector, N. D. Carter, and S. D. O'Dell, “Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population,” Diabetes, vol. 54, no. 11, pp. 3296–3304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Cheyssac, C. Lecoeur, A. Dechaume et al., “Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population,” BMC Medical Genetics, vol. 7, article 44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. K. P. Burdon, J. L. Bento, C. D. Langefeld et al., “Association of protein tyrosine phosphatase-N1 polymorphisms with coronary calcified plaque in the diabetes heart study,” Diabetes, vol. 55, no. 3, pp. 651–658, 2006. View at Google Scholar · View at Scopus
  66. J. C. Florez, C. M. Agapakis, N. P. Burtt et al., “Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people,” Diabetes, vol. 54, no. 6, pp. 1884–1891, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Traurig, R. L. Hanson, S. Kobes, C. Bogardus, and L. J. Baier, “Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians,” Diabetologia, vol. 50, no. 5, pp. 985–989, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Wanic, M. T. Malecki, T. Klupa, J. H. Warram, J. Sieradzki, and A. S. Krolewski, “Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetes,” Diabetic Medicine, vol. 24, no. 6, pp. 650–655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Di Paola, L. Frittitta, G. Miscio et al., “A variation in 3'UTR of hPTP1B increases specific gene expression and associates with insulin resistance,” American Journal of Human Genetics, vol. 70, no. 3, pp. 806–812, 2002. View at Publisher · View at Google Scholar
  70. R. Meshkani, M. Taghikhani, A. Mosapour et al., “1484insG polymorphism of the PTPN1 gene is associated with insulin resistance in an Iranian population,” Archives of Medical Research, vol. 38, no. 5, pp. 556–562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. D. Bodhini, V. Radha, S. Ghosh, P. P. Majumder, and V. Mohan, “Lack of association of PTPN1 gene polymorphisms with type 2 diabetes in south Indians,” Journal of Genetics, vol. 90, no. 2, pp. 323–326, 2011. View at Publisher · View at Google Scholar
  72. I. Dahlman, H. Wahrenberg, L. Persson, and P. Arner, “No association of reported functional protein tyrosine phosphatase 1B 3′ UTR gene polymorphism with features of the metabolic syndrome in a Swedish population,” Journal of Internal Medicine, vol. 255, no. 6, pp. 694–695, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. S. M. Echwald, H. Bach, H. Vestergaard et al., “A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro,” Diabetes, vol. 51, no. 1, pp. 1–6, 2002. View at Google Scholar · View at Scopus
  74. M. Malodobra, A. Pilecka, B. Gworys, and R. Adamiec, “Single nucleotide polymorphisms within functional regions of genes implicated in insulin action and association with the insulin resistant phenotype,” Molecular and Cellular Biochemistry, vol. 349, no. 1-2, pp. 187–193, 2011. View at Google Scholar
  75. H. J. L. Speirs, K. Katyk, N. N. Kumar, A. V. Benjafield, W. Y. S. Wang, and B. J. Morris, “Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension,” Journal of Hypertension, vol. 22, no. 5, pp. 931–936, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Weng, J. Yan, Z. Huang, Y. Sui, and L. Xiu, “Missense mutation of Pro387Leu in protein tyrosine phosphatase-1B (PTP-1B) is not associated with type 2 diabetes in a Chinese Han population,” Diabetes Care, vol. 26, no. 10, article 2957, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Santaniemi, O. Ukkola, and Y. A. Kesäniemi, “Tyrosine phosphatase 1B and leptin receptor genes and their interaction in type 2 diabetes,” Journal of Internal Medicine, vol. 256, no. 1, pp. 48–55, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. I. Gouni-Berthold, E. Giannakidou, D. Müller-Wieland et al., “The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population,” Journal of Internal Medicine, vol. 257, no. 3, pp. 272–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. O. Ukkola, T. Rankinen, T. Lakka et al., “Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism,” Obesity Research, vol. 13, no. 5, pp. 829–834, 2005. View at Google Scholar · View at Scopus
  80. S. Kipfer-Coudreau, D. Eberlé, M. Sahbatou et al., “Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects,” Diabetologia, vol. 47, no. 7, pp. 1278–1284, 2004. View at Google Scholar · View at Scopus
  81. J. Mo, J. Wu, Z. Sun, H. Yang, M. Lei, and W. Liu, “Association of PTP1B gene polymorphism with obesity in Chinese children,” Journal of Central South University. Medical Sciences, vol. 35, no. 9, pp. 915–920, 2010. View at Google Scholar
  82. A. Mok, H. Cao, B. Zinman et al., “A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in oji-cree,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 724–727, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Gu, W. Jiang, H. Du et al., “Protein tyrosine phosphatase 1B gene polymorphisms and essential hypertension: a case-control study in Chinese population,” Journal of Endocrinological Investigation, vol. 33, no. 7, pp. 483–488, 2010. View at Google Scholar
  84. R. Meshkani, M. Taghikhani, H. Al-Kateb et al., “Polymorphisms within the protein tyrosine phosphatase IB (PTPN1) gene promoter: functional characterization and association with type 2 diabetes and related metabolic traits,” Clinical Chemistry, vol. 53, no. 9, pp. 1585–1592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Wada, T. Sasaoka, M. Funaki et al., “Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity,” Molecular and Cellular Biology, vol. 21, no. 5, pp. 1633–1646, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Sasaoka, H. Hori, T. Wada et al., “SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes,” Diabetologia, vol. 44, no. 10, pp. 1258–1267, 2001. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Vollenweider, M. Clodi, S. S. Martin, T. Imamura, W. M. Kavanaugh, and J. M. Olefsky, “An SH2 domain-containing 5' inositolphosphatase inhibits insulin- induced GLUT4 translocation and growth factor-induced actin filament rearrangement,” Molecular and Cellular Biology, vol. 19, no. 2, pp. 1081–1091, 1999. View at Google Scholar · View at Scopus
  88. S. Clément, U. Krause, F. Desmedt et al., “The lipid phosphatase SHIP2 controls insulin sensitivity,” Nature, vol. 409, no. 6816, pp. 92–97, 2001. View at Publisher · View at Google Scholar
  89. S. Clément, U. Krause, F. Desmedt et al., “Corrigendum: the lipid phosphatase SHIP2 controls insulin sensitivity,” Nature, vol. 431, no. 7010, pp. 878–878, 2004. View at Google Scholar
  90. M. W. Sleeman, K. E. Wortley, K. M. V. Lai et al., “Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity,” Nature Medicine, vol. 11, no. 2, pp. 199–205, 2005. View at Publisher · View at Google Scholar
  91. X. Xu, J. J. Rogus, H. A. Terwedow et al., “An extreme-sib-pair genome scan for genes regulating blood pressure,” American Journal of Human Genetics, vol. 64, no. 6, pp. 1694–1701, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. C. I. M. Panhuysen, L. A. Cupples, P. W. F. Wilson, A. G. Herbert, R. H. Myers, and J. B. Meigs, “A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study,” Diabetologia, vol. 46, no. 4, pp. 579–587, 2003. View at Google Scholar · View at Scopus
  93. K. Silander, L. J. Scott, T. T. Valle et al., “A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14,” Diabetes, vol. 53, no. 3, pp. 821–829, 2004. View at Publisher · View at Google Scholar
  94. E. Marion, P. J. Kaisaki, V. Pouillon et al., “The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man,” Diabetes, vol. 51, no. 7, pp. 2012–2017, 2002. View at Google Scholar · View at Scopus
  95. P. J. Kaisaki, M. Delépine, P. Y. Woon et al., “Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome,” Diabetes, vol. 53, no. 7, pp. 1900–1904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. A. C. B. Marçano, B. Burke, J. Gungadoo et al., “Genetic association analysis of inositol polyphosphate phosphatase-like 1 (INPPL1, SHIP2) variants with essential hypertension,” Journal of Medical Genetics, vol. 44, no. 9, pp. 603–605, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Kagawa, T. Sasaoka, S. Yaguchi et al., “Impact of Src homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2911–2919, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Matsushima, N. Harada, N. J. G. Webster, Y. M. Tsutsumi, and Y. Nakaya, “Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity,” The Journal of Biological Chemistry, vol. 281, no. 40, pp. 29719–29729, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. J. Liu, X. Wu, J. L. Franklin et al., “Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance,” American Journal of Physiology—Endocrinology and Metabolism, vol. 298, no. 3, pp. E565–E576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Prudente, M. L. Hribal, E. Flex et al., “The functional Q84R polymorphism of mammalian tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy,” Diabetes, vol. 54, no. 9, pp. 2807–2811, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. C. W. Liew, J. Bochenski, D. Kawamori et al., “The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse β cells,” The Journal of Clinical Investigation, vol. 120, no. 8, pp. 2876–2888, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. F. Andreozzi, G. Formoso, S. Prudente et al., “TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1355–1360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Prudente, D. Scarpelli, M. Chandalia et al., “The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 190–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Prudente, R. Baratta, F. Andreozzi et al., “TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion,” Diabetologia, vol. 53, no. 7, pp. 1354–1361, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. C. R. Kahn, “Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes,” Experimental Diabesity Research, vol. 4, no. 3, pp. 169–182, 2003. View at Google Scholar · View at Scopus
  106. E. Morini, S. Prudente, E. Succurro et al., “IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'low-frequency-low-risk' variants,” Diabetologia, vol. 52, no. 9, pp. 1852–1857, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Bacci, S. Prudente, M. Copetti et al., “Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance,” Atherosclerosis, vol. 226, no. 1, pp. 140–145, 2013. View at Publisher · View at Google Scholar
  108. A. Doria, M. E. Patti, and C. R. Kahn, “The emerging genetic architecture of type 2 diabetes,” Cell Metabolism, vol. 8, no. 3, pp. 186–200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. N. Grarup and G. Andersen, “Gene-environment interactions in the pathogenesis of type 2 diabetes and metabolism,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 4, pp. 420–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. M. C. Cornelis, E. J. T. Tchetgen, L. Liang et al., “Gene-environment interactions in genome-wide association studies: a comparative study of tests applied to empirical studies of type 2 diabetes,” American Journal of Epidemiology, vol. 175, no. 3, pp. 191–202, 2012. View at Publisher · View at Google Scholar
  111. M. L. Metzker, “Sequencing technologies—the next generation,” Nature Reviews Genetics, vol. 11, no. 1, pp. 31–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. M. I. McCarthy, P. Rorsman, and A. L. Gloyn, “TCF7L2 and diabetes: a tale of two tissues, and of two species,” Cell Metabolism, vol. 17, no. 2, pp. 157–159, 2013. View at Publisher · View at Google Scholar